Speaker illustration

Ms Marjolein Brekelmans

Amsterdam (Netherlands (The))

Clinical impact and course of major bleeding events in patients with venous thromboembolism, treated with factor Xa inhibitors or vitamin K antagonists: an individual patient data analysis

Event: ESC CONGRESS 2016

Topic: Medical treatment

Session: Young Investigators Awards Session Thrombosis

Thumbnail

This platform is supported by

logo Novo Nordisk